Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
Article CAS PubMed Google Scholar
Dar, A. C. & Shokat, K. M. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu. Rev. Biochem. 80, 769–795 (2011).
Article CAS PubMed Google Scholar
Cohen, P., Cross, D. & Jänne, P. A. Kinase drug discovery 20 years after imatinib: progress and future directions. Nat. Rev. Drug Discov. 20, 551–569 (2021).
Article CAS PubMed PubMed Central Google Scholar
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S. & Schiöth, H. B. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat. Rev. Drug Discov. 20, 839–861 (2021).
Article CAS PubMed Google Scholar
Kung, J. E. & Jura, N. Prospects for pharmacological targeting of pseudokinases. Nat. Rev. Drug Discov. 18, 501–526 (2019).
CAS PubMed PubMed Central Google Scholar
Oprea, T. I. et al. Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov. 17, 317–332 (2018).
Article CAS PubMed PubMed Central Google Scholar
Leonard, C. J., Aravind, L. & Koonin, E. V. Novel families of putative protein kinases in bacteria and archaea: evolution of the “eukaryotic” protein kinase superfamily. Genome Res. 8, 1038–1047 (1998).
Article CAS PubMed Google Scholar
Pagliarini, D. J. et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112–123 (2008).
Article CAS PubMed PubMed Central Google Scholar
Lundquist, P. K., Davis, J. I. & van Wijk, K. J. ABC1K atypical kinases in plants: filling the organellar kinase void. Trends Plant Sci. 17, 546–555 (2012).
Article CAS PubMed PubMed Central Google Scholar
Traschütz, A. et al. Clinico‐genetic, imaging and molecular delineation of COQ8A‐ataxia: a multicenter study of 59 patients. Ann. Neurol. 88, 251–263 (2020).
Article PubMed PubMed Central Google Scholar
Stefely, J. A. et al. Cerebellar ataxia and coenzyme Q deficiency through loss of unorthodox kinase activity. Mol. Cell 63, 608–620 (2016).
Article CAS PubMed PubMed Central Google Scholar
Ashraf, S. et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179–5189 (2013).
Article CAS PubMed PubMed Central Google Scholar
Poon, W. W. et al. Identification of Escherichia coli ubiB, a gene required for the first monooxygenase step in ubiquinone biosynthesis. J. Bacteriol. 182, 5139–5146 (2000).
Article CAS PubMed PubMed Central Google Scholar
Do, T. Q., Hsu, A. Y., Jonassen, T., Lee, P. T. & Clarke, C. F. A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants. J. Biol. Chem. 276, 18161–18168 (2001).
Article CAS PubMed Google Scholar
Stefely, J. A. & Pagliarini, D. J. Biochemistry of mitochondrial coenzyme Q biosynthesis. Trends Biochem. Sci. 42, 824–843 (2017).
Article CAS PubMed PubMed Central Google Scholar
Stefely, J. A. et al. Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthesis. Mol. Cell 57, 83–94 (2015).
Article CAS PubMed Google Scholar
Reidenbach, A. G. et al. Conserved lipid and small-molecule modulation of COQ8 reveals regulation of the ancient kinase-like UbiB family. Cell Chem. Biol. 25, 154–165 (2018).
Article CAS PubMed Google Scholar
Asquith, C. R. M., Murray, N. H. & Pagliarini, D. J. ADCK3/COQ8A: the choice target of the UbiB protein kinase-like family. Nat. Rev. Drug Discov. 18, 815 (2019).
Article CAS PubMed PubMed Central Google Scholar
Murray, N. H. et al. 2-Propylphenol allosterically modulates COQ8A to enhance ATPase activity. ACS Chem. Biol. 17, 2031–2038 (2022).
Article CAS PubMed Google Scholar
Asquith, C. R. M. et al. SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK). J. Med. Chem. 62, 2830–2836 (2019).
Article CAS PubMed PubMed Central Google Scholar
Wells, C. I. et al. The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification. Int. J. Mol. Sci. 22, 566 (2021).
Article CAS PubMed Central Google Scholar
Robers, M. B. et al. Target engagement and drug residence time can be observed in living cells with BRET. Nat. Commun. 6, 10091 (2015).
Article CAS PubMed Google Scholar
Vasta, J. D. et al. Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement. Cell Chem. Biol. 25, 206–214 (2018).
Article CAS PubMed PubMed Central Google Scholar
Lagier-Tourenne, C. et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am. J. Hum. Genet. 82, 661–672 (2008).
Article CAS PubMed PubMed Central Google Scholar
Fonseca, L. V. et al. Mutations in COQ8B (ADCK4) found in patients with steroid-resistant nephrotic syndrome alter COQ8B function. Hum. Mutat. 39, 406–414 (2017).
Rensvold, J. W. et al. Defining mitochondrial protein functions through deep multiomic profiling. Nature 606, 382–388 (2022).
Article CAS PubMed Google Scholar
Zielonka, J. et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117, 10043–10120 (2017).
Article CAS PubMed PubMed Central Google Scholar
Smith, R. A. J., Porteous, C. M., Gane, A. M. & Murphy, M. P. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl Acad. Sci. USA 100, 5407–5412 (2003).
Article CAS PubMed PubMed Central Google Scholar
Trionnaire, S. L. et al. The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3 H -1,2-dithiol-5-yl)phenoxy)decyl)triphenylphosphonium bromide (AP39). MedChemComm 5, 728–736 (2014).
Trnka, J., Elkalaf, M. & Anděl, M. Lipophilic triphenylphosphonium cations inhibit mitochondrial electron transport chain and induce mitochondrial proton leak. PLoS ONE 10, e0121837 (2015).
Article PubMed PubMed Central Google Scholar
Reily, C. et al. Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol. 1, 86–93 (2013).
Article CAS PubMed PubMed Central Google Scholar
Duncan, J. S. et al. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 149, 307–321 (2012).
Article CAS PubMed PubMed Central Google Scholar
Asquith, C. R. M. et al. Identification and optimization of 4-anilinoquinolines as inhibitors of cyclin G associated kinase. ChemMedChem 13, 48–66 (2018).
Article CAS PubMed Google Scholar
Asquith, C. R. M. et al. Design of a cyclin G associated kinase (GAK)/epidermal growth factor receptor (EGFR) inhibitor set to interrogate the relationship of EGFR and GAK in chordoma. J. Med. Chem. 62, 4772–4778 (2019).
Article CAS PubMed Google Scholar
Asquith, C. R. M. et al. Identification of 4-anilinoquin(az)oline as a cell-active protein kinase novel 3 (PKN3) inhibitor chemotype. ChemMedChem 17, e202200161 (2022).
Asquith, C. R. M. et al. Design and analysis of the 4‐anilinoquin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure–activity relationships. ChemMedChem 15, 26–49 (2020).
Article CAS PubMed Google Scholar
Serafim, R. A. M., Elkins, J. M., Zuercher, W. J., Laufer, S. A. & Gehringer, M. Chemical probes for understudied kinases: challenges and opportunities. J. Med. Chem. 65, 1132–1170 (2022).
留言 (0)